The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price ...

The Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of Viridian Metals Inc. ("Viridian" or the "Company"). The Company's common shares, which were previously listed ...

Viridian Metals (TSXV: VRDN) announced Friday it has expanded its land position in Canada’s Labrador through staking, securing 2,600 km² of the prospective Seal Basin. This newly acquired ...

Viridian Metals Inc. (TSXV: VRDN) ("Viridian or the "Company") is pleased to announce that it has received the approval of ...